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Cardiac
Abnormalities in
Rhythm and
Diastolic function due to
Inactivity,
Atrophy and
Confinement
https://ntrs.nasa.gov/search.jsp?R=20090010235 2019-08-30T06:24:59+00:00Z

Experimental Overview:
Pre-Flight In-Flight Post-Flight
• Ambulatory ECG,
blood pressure, and 
 
• Ambulatory ECG,
blood pressure, and 
 
• Ambulatory ECG,
blood pressure, and 
ti it  it iactivity monitoring
(24-48 hr);
• Rest and exercise echo
activity monitoring
(24 hr);
• Rest and exercise echo 
ac v y mon or ng
(24 hr);
• Rest and exercise echo
• Magnetic Resonance 
Imaging (Cardiac MRI) 
after 2 & 4 weeks, 
then every 30-60 days • MRI (Russia and US)
in US and Russia
• Tilt for moon, mars &
th it
• Tilt for moon, mars &
earth gravity on R+0ear grav y
Global Objective: To carefully quantify the effects of 
long duration spaceflight on the structure and function 
of the heart
And to determine its clinical consequences for:
a).  Orthostatic Tolerance (ability to stand up) 
under moon, mars, and earth gravity;
b).  Risk for Cardiac Arrhythmias (if any…);
c).  To determine if current countermeasures already are 
sufficient to prevent any clinically meaningful problems.
Background
Orthostatic C t pl x
Hypotension
(low blood pressure on 
standing)
a a e y
(sudden falling asleep)
Hysterical
Syncope
(fainting due to emotional
causes)
Key Characteristic of Cardiovascular Adaptation to Space:
A Low Stroke Volume in the Upright Position
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Levine et al, J Physiol 2002 BL=Baseline
Cardiac Atrophy After Spaceflight
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Left Ventricular Mass Continues to Decrease
Over 12 Weeks of Bedrest
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Dorfman et al, JAP 2008
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EE =  Velocity of blood motion
E’
Vp
E’ =  Velocity of heart motion
Vp = Propagation Velocity
LBNP= Lower Body Negative 
Pressure
Echo/Doppler measurements used to assess diastolic function (how well the heart 
relaxes) in relation to how much volume is in the heart (pulmonary capillary wedge 
(PCW) pressure                                     Pacini et al, JACC 2007
Clinical Implications of Cardiac Atrophy for
h l h d f  d i  l  d iea t an sa ety ur ng ong urat on
spaceflight
1 ? magnitude, rate of change, and plateau over
ti  i  fli htme n g
2 ? does more severe atrophy more severe
th t ti  i t l  or os a c n o erance
3 ? what are the implications for systolic and
diastolic performance
4 ? does atrophy occur by apoptosis
(programmed cell death)  or fibrosis (scarring)
Fritsch-Yelle et al, Am J Cardio 1998
, ,
and could this pre-dispose to arrhythmias
1 .4
McGavock et al Circulation 2007
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Vigorous
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No 
Training
Cardiovascular Magnetic Resonance Image From a 36-Year-Old Hypertrophic 
Cardiomyopathy Patient (heart muscle has become too thick)
Adabag, A. S. et al. J Am Coll Cardiol 2008;51:1369-1374
DE = Delayed Enhancement
NSVT = Non-Sustained Ventricular Tachycardia
PVC = Premature Ventricular Contractions
SVT = Supraventricular Tachycardia
HR = Heart Rate
The Cardiac Action Potential
Depolarization Repolarization
Ito
I
Inward Outward
kr
Iks
INa
ICa
Current Current
-80mV
QRS
T wave
ST
 
NSVT = Non-Sustained Ventricular Tachycardia
TWA = T-Wave Alternans
~ 1/1000 Negative 
Predictive Value
Ikeda et al, JACC 2006 LP = late potentials from signal averaged ECG
Hypotheses
1a. Cardiac atrophy occurs in humans after prolonged spaceflight as a 
function of both the basal hemodynamics of microgravity (reduced 
wall stress and volume load) and a reduction in physical activity.
1b. Cardiac atrophy develops progressively during long-duration 
spaceflight, but eventually plateaus in response to a new steady-
state of cardiac work. 
2. Cardiac atrophy during prolonged spaceflight limits the utilization 
of diastolic suction and impairs ventricular relaxation and filling 
both at rest and during gravitational transitions.  This impairment 
of diastolic function leads to impaired systolic function (by 
limiting cardiac filling) and, in combination with hypovolemia, is 
the primary mechanism leading to a reduced stroke volume during 
orthostasis after spaceflight and reduced exercise capacity.
3. Prolonged spaceflight leads to alterations in ventricular 
conduction  repolarization and refractoriness  and an increase in , ,
the frequency of arrhythmias.
Session 
Descriptions
(Pre/Postflight and 
Inflight)
PIs:  Mike Bungo and Ben Levine
Integrated Cardiovascular
Human Research Program Informed Consent Briefing
48 or 24 hr Blood Pressure (BP)/Holter/Activity Monitoring
Pre-flight (48 hr): Between L-75 & L-60 and between L-21 & L-7 (two total)
Post-flight (24 hr): R+0
Synopsis:
Upon arrival, the crewmember will be instrumented with the Ambulatory BP, Holter Monitor and Activity Monitor (waist and 
ankle) devices for 48 hours (preflight) or 24 hours (postflight) A signal check and/or memory card change out will occur
Crew Time – 30 min
         .        -    
part way through the recording period to ensure an adequate signal is being obtained.  Preflight, the BP Monitor will be 
removed at that time. Signal check and hardware removal will be at any location convenient for the crew.
Constraints:
• Hardware cannot be immersed in water No swimming or showering during session (sponge bath OK)     .          .
• No Neutral Buoyancy Laboratory (NBL) runs during the 48 hour period.
• A 10 minute period of quiet rest (indicated by an event marker) is needed during the session. 
• Preflight, exercise with heart rate greater than or equal to 120 for at least 10 minutes must be performed at some time 
during this session.
• Postflight, prefer no high intensity exercise or blood pressure manipulation within first 2 hrs after donning; however, 
1440 or 720 min15 min
BP/Holter/Activity Monitor
1440 or 720 min10 min
Signal Check;
5 min
Holter/Activity
session should not be delayed to accommodate this request
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Passive
Recording
  
Instrumentation Passive
Recording
 
BP Removal Monitor Removal

PIs:  Mike Bungo and Ben Levine
Integrated Cardiovascular
Human Research Program Informed Consent Briefing
24 hr BP/Holter/Activity Monitoring
Within 1 week (preferably +3 days) of 
Resting/Exercise Echo Sessions
Crew Time – 65 min
  
(Approx. FD14-15, 30-31, 75-76, 135-136, and R-15-14)
Synopsis:
In association with each of the inflight Echocardiogram (Echo) sessions, the subject will prepare the electrode sites (10), 
apply the electrodes connect the 12 lead harness secure the electrodes/lead wires and set up the Holter monitor The  ,   -  ,    ,  -    .   
subject will then don the activity monitors (one at the waist and one at the ankle), select the appropriate finger cuffs, don
the blood pressure monitor and configure it for operation.  Operator assistance is requested for a portion of this session.  
Periodic battery swaps (Makita drill batteries) will be required for the blood pressure monitor.  All data collected will be 
stored digitally.  The subject will doff all devices after 24 hours and the data will be downloaded within five days of session 
completion.  This session will ideally be performed 24 hrs before or immediately after the inflight Echo sessions for crew 
Constraints:
• The date of this session must be ± 1 week (preferably within 3 days) of the inflight Echo sessions.
• Time savings can be realized if performed 24 hrs prior to or immediately after a Resting or Exercise Echo session.
• Exercise with heart rate greater than or equal to 120 for at least 10 minutes must be performed at some time during this 
session Also a 10 minute period of quiet rest (indicated by an event marker) is needed
time savings. 
. ,              .
1440 min*
Passive
Recording
15 min
Unstow hardware
20 min
Hardware Activation and 
Subject Instrumentation
15 min
Stow Hardware
5 min
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* Indicates unattended session time 
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Holter and Ambulatory Blood Pressure Risks
Risks:
None
Discomforts:
• skin irritation from electrodes
• finger cuff is annoying (turns finger blue)
• gets in way of normal activities
PIs:  Mike Bungo and Ben Levine
Integrated Cardiovascular
Human Research Program Informed Consent Briefing
Resting Echo/ECG
Pre-flight: Between L-21 and L-7 (one time)
Crew Time – 30 or 60* min
Post-flight: R+7
Synopsis:
Upon arrival, the crewmember will be instrumented and a 12-lead ECG (for Signal Averaged ECG and QT Dispersion) will 
then be recorded A Resting Echo for diastolic function will follow (some chest electrodes will be removed for ultrasound
Constraints:
• Subjects should have a minimum 6 hours sleep during previous night after no more than an 18 hour work day.
• No caffeine, alcohol, or tobacco for 24 hrs prior to session.
  .                  
probe access).  After all measurements are complete, the remaining electrodes will be removed.
• No over-the-counter cold medication for 36 hrs prior to the session.
• No maximal exercise (≥80% max HR for more than 30 min) for the 12 hrs prior to session.
• No meals within 2 hours preceding this test. A light snack of complex carbohydrates is acceptable within 2 hours.
• Females should wear a sports bra or bikini top for echo probe access. 
* It is highly desired that the in-flight operator attend the preflight session with the subject to provide additional ultrasound 
i / b ti l t i i l t fli htexper ence o serva ona  ra n ng c ose o g .
20 min
Subject Scan (ECG
5 min
Subject
5 min
Subject
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followed by Resting Echo)
 
De-instrumentation
 
Instrumentation
PIs:  Mike Bungo and Ben Levine
Integrated Cardiovascular
Human Research Program Informed Consent Briefing
Resting Echo
FD 14 (±4), 30 (±5), 135 (±5), and R-15 (±4) Crew Time – 170 min
•Unstow Hardware
•Setup Ultrasound 
65 min 10 min
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Scan
5 min*
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Unattended20 min
Ultrasound 
System 
Sh td(USND) & Crew Medical 
Restraint System 
(CMRS)
•Turn on USND & PC
•Perform USND Hard 
Drive clean up
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Constraints:
• Ku-band and S-band needed for real-time remote guidance during scanning (downlink of ultrasound video and two-way 
 -
•Open a new patient file
•Reserve Cabin Video
audio).  Real-time (RT) cabin video also requested.
• No exercise, strenuous physical activities, or Extravehicular Activity (EVA) within 4 hrs preceding subject scan. 
• No large meal within 2 hours preceding subject scan. A light snack of complex carbohydrates is acceptable within 2 hours.
• Video and audio communications should be private to the Telescience Support Center (TSC) (restricted access is required 
for video and voice loops due to medically sensitive information).
24
* Indicates both subject and operator required Unattended session time 

PIs:  Mike Bungo and Ben Levine
Integrated Cardiovascular
Human Research Program Informed Consent Briefing
Exercise Echo/ECG
Pre-flight: Between L-75 and L-60 (one time)
Crew Time – 36 min
Post-flight: R+4 and R+14
Synopsis:
Upon arrival, limb leads for ECG will be placed and the area of the chest which provides optimal echo images will be 
located.  Chest electrodes will then be placed, taking care to avoid ultrasound probe-use locations.  Baseline 
t f ECG d E h f di t li f ti ill b t k Th b ill th b i t (2) fi i t
Constraints:
measuremen s o   an  c o or as o c unc on w  e a en.  e crewmem er w  en eg n wo  ve-m nu e 
submaximal workloads on the bicycle ergometer (one at 30% and the other at 60% of maximum work rate).  Echo 
measurements will be taken with the subject at rest after each workload level while ECG will be recorded throughout the 
session (both rest and exercise).
• Subjects should have a minimum 6 hours sleep during previous night after no more than an 18 hour work day.
• No caffeine, alcohol, or tobacco for 24 hrs prior to session.
• No over-the-counter cold medication for 36 hrs prior to session.
• No maximal exercise (≥80% max heart rate for more than 30 min) for the 12 hrs prior to session.
• No meals within 2 hrs preceding test. A light snack of complex carbohydrates is acceptable within 2 hours. 
• Subject should wear athletic clothing and shoes for the session; females should wear a sports bra or bikini top for echo                     
probe access.
• Approval of crew surgeon for exercise at 30% and 60% maximum work rate needed for R+4 session. 
12 min
Resting
2 min
Echo
5 min
Exercise
5 min
Exercise
2 min
Echo
5 min
Subject
5 min
Subject De
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Echo @
Rest
@ 30% Max 
Work Rate
@ 60% Max
Work Rate
at
Rest
 
Instrumentation
  -
instrumentation
PIs:  Mike Bungo and Ben Levine
Integrated Cardiovascular
Human Research Program Informed Consent Briefing
Exercise Echo
FD75 (±5)
Crew Time – 265 min
•Unstow Hardware
•Setup USND & CMRS
•Turn on USND & PC
65 min 10 min
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20 min
Exercise
35 min*
Repeat
Scan
30 min*
Resting
Scan
5 min*
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Unattended20 min
Ultrasound 
System 
Shutdown
•Perform USND Hard 
Drive clean-up
•Open a new patient file
•Reserve Cabin Video
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Constraints/Notes:
• Repeat scan must be done immediately (<5 min) after exercise or additional exercise must be performed. 
• Exercise must include at least 5 continuous minutes at a heart rate of at least 70% of the max heart rate predicted or 
achieved during pre-flight testing (exact guidelines established during BDC).
• Ku-band and S-band needed for real time remote guidance during scanning (downlink of ultrasound video and two-way 
audio).  RT cabin video also required.
• No exercise, strenuous physical activities, or EVA within 4 hrs preceding scan.
• No large meal within 2 hours preceding scan. A light snack of complex carbohydrates is acceptable within 2 hours.
• Video and audio communications should be private to the TSC (restricted access is required for video and voice loops 
due to medically sensitive information).
( ’ ) f
27 * Indicates both subject and operator required
• Exercise period can be longer to encompass crewmember s nominal exercise  i  certain conditions are met.
Unattended session time 
Echocardiography Session Risks
Risks:
• None for the Echo (Ultrasound) itself
• Exercise rarely causes problems in normal 
subjects (individuals with heart disease could 
i  h  i  di i  i l  exper ence c est pa n, zz ness, rregu ar
heart rhythms or even heart attack).  Your 
risk of heart attack is slight (less than 1 in 
100,000 tests).
Discomforts:
• ultrasound gel is messy
• skin irritation from electrodes
i   k   ti d d f t bl• exerc se can ma e you re an uncom or a e
Privacy Concerns
Inflight ultrasound scans will be viewed by more than just 
the Principal Investigators (PIs):
 f   ill b  h   d h   h     • one o your crewmates w e t e operator an e or s e may or may
not be able to interpret the scan
• the remote guider will (obviously) need to see the data to direct the 
on-orbit operator - he/she will be located in JSC’s Telescience 
Support Center (TSC) with 2-way audio and one-way video to 
communicate with the operator.
• others in the TSC and at PI console locations (such as hardware 
n in s  PI s pp t p s nn l  t ) ill s  th  s ns
Mission Control Center-Houston (MCC-H) and Payload 
Operations Integration Center (POIC) will NOT be able to 
e g eer , u or er o e , e c. w ee e ca
see the scans (privatized).  Neither will your crew surgeon 
unless you specifically give your permission.  ALL personnel 
in the TSC and at PI console locations (e.g., Dallas) will 
know that the data itself and any conversations regarding 
it are to remain strictly confidential.
PIs:  Mike Bungo and Ben Levine
Integrated Cardiovascular
Human Research Program Informed Consent Briefing
Cardiac Function
Pre-flight: Between L-75 and L-60 (one time)
Crew Time – 75 (preflight) or 60 (postflight) min
Post-flight: R+0 (some instrumentation/testing in Kazakhstan if possible)
Synopsis:
The subject will be instrumented with a pneumograph, ECG electrodes, Finapres, and blood pressure cuff and a baseline 
protocol (including controlled frequency breathing, ECG and echo/Doppler recordings) will follow.  The tilt table will then be 
tilt d t 10 d f 2 i t hil h t t d bl d t t k Th tilt l ill th b
Constraints:
N ff i l h l t b f 24 h i t i
e  o  egrees or  m nu es w e ear  ra e an  oo  pressure measuremen s are a en.  e  ang e w  en e 
increased to 22 degrees for 5 minutes and the echo measurements repeated.  The same procedure is followed for tilt 
angles of 41 degrees and 80 degrees.  At all tilt angles other than 10 degrees, measurements will be taken as at baseline, 
including echo/Doppler, heart rate and blood pressure.
• o ca e ne, a co o , or o acco or  rs pr or o sess on.
• No over-the-counter cold medication for 36 hrs prior to session; preferably no Midodrine on landing day.
• No meals within 2 hrs preceding test. A light snack of complex carbohydrates is acceptable within 2 hours.
• Females should wear a sports bra or bikini top for echo probe access. 
• Preflight, subjects should have a minimum 6 hours sleep during previous night after no more than an 18 hour work day 
with no maximal exercise (≥80% max HR for more than 30 min) for the 12 hrs prior to session                  .
• Kentavr suits (if worn) must be removed for this session.
10-15 min 16-20 min
Baseline Protocol
(controlled frequency
2 min 9-10 min 2-3 min
Tilt 
recovery
9-10 min 3-5 min9-10 min
Subject
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Cardiac Function Session Risks
Risks:
• Slight risk of near fainting during 80 deg tilt 
(we’ll be monitoring your heart rate and blood 
pressure and stop the test early, if necessary)
Discomforts:
• ultrasound gel is messy
• skin irritation from electrodes
• finger cuff is annoying (turns finger blue)
PIs:  Mike Bungo and Ben Levine
Integrated Cardiovascular
Human Research Program Informed Consent Briefing
Magnetic Resonance Imaging (MRI)
Pre flight: Between L 75 and L 60 in US (one time)
Crew Time – 180 min US; 360* min Russia
-    -   -                                               
-Additional session in Russia if Russian landing is planned
Post-flight:  R+3 (±1 day) and between R+22 and R+30 (two total)
Synopsis:
The crewmember will be picked up and transported to UT-Houston (in the Texas Medical Center) or CRC (in Moscow) for 
an MRI of their heart.  Upon arrival, the crewmember will remove all metal (e.g., jewelry, belt) and magnetically sensitive 
items (e.g., credit cards, “smart” badges) and don a scrub shirt.  An IV will then be started (for later gadolinium 
administration) and three electrodes will be placed on the chest.  Baseline scans (including Magnetic Resonance 
Spectroscopy or MRS) will then be performed with the crewmember in the supine position.  Following the baseline scans, 
Constraints:
• Session cannot be scheduled during Blood Pressure/Holter/Activity Monitoring sessions.
gadolinium will be administered intravenously and a subset of the scans will be repeated.  After all scans are complete, the 
electrodes and IV will be removed and the crewmember will change back into his/her regular shirt, retrieve doffed items, 
and be transported back to his/her original location.
90 min45 (US) or 135 (Russia) min 45 (US) or 135 (Russia) min
• If gadolinium will be administered, documentation of normal renal function (normal serum creatinine levels) is required.
• Pregnancy testing requirements for female subjects will be determined by the crew surgeon prior to each test session. 
• Females may wish to wear a sports bra (must not contain metal).
32
MRI (includes MRS & gadolinium-
enhanced scans)
Travel Time Travel Time

Ri k
MRI Risks
s s:
• Nephrogenic Systemic Fibrosis – this is a rare disorder 
which has occurred in patients with kidney failure getting 
MRI contrast.  It results in hardening of the skin and 
possibly other organs and has been fatal   It ALWAYS.
occurs in patients who either are on dialysis, or who are 
in acute kidney failure.  It has NEVER occurred in more 
th n 220 milli n p ti nts h  h  h d MRI c nt st nd a o a e w o ave a o ra a
have normal kidney function.  We will check a simple 
blood test to ensure your kidney function is normal.
• Metal implants/embedded metal objects – these can 
cause problems (metal can move or burn, etc.) because of 
the magnets used   Let us know if you have implants or .
have done a lot of welding/metal grinding or have metallic 
ink tattoos.
MRI Risks
Risks (continued):
• Infection/Blood Clot –very small risk as a result of 
insertion of the intravenous catheter for the gadolinium 
(as with any needle “stick”, our personnel are trained to 
d  hi  d h  ill  h   i   o t s an t ey w use t e proper equ pment to
minimize this possibility). 
Discomforts:
• claustrophobia
• needle “stick” for IV
• loud machine
b i• or ng
PIs:  Mike Bungo and Ben Levine
Integrated Cardiovascular
Human Research Program Informed Consent Briefing
Exercise/Medication Logs
Pre-flight: L-105 through Launch (daily)
In flight: Throughout the flight (daily)
Crew Time – 0 min
-               
Post-flight: R+0 through R+30 (daily)
Synopsis:
The subject will log exercise device duration and intensity for all exercise performed pre- in- and post-flight Preflight     , ,       , ,  .   
logs will most likely need to be kept by the subject.  Inflight and postflight logs are typically obtained via data sharing. 
Medications will also be logged or obtained via data sharing.  Blood parameters (e.g., hematology, chemistry profiles, etc.) 
will be obtained solely via data sharing from blood analyses performed as part of medical requirements testing.
0 min
Data Sharing (in- and postflight)
Or
Personal Time (preflight)
Constraints:
• Logging should begin 30 days prior to the first Integrated Cardiovascular BDC session.
36
            
• Exercise and medication data will be requested via data sharing or logged on personal time (reminder notes may be 
placed on the crew schedule for the latter). Blood parameters will be obtained solely via data sharing.
Session Summary
PRE-FLIGHT IN-FLIGHT POST-FLIGHT
Exercise Echo/ECG
• Between L-75 & L-60
OCBT (Reserve)
Within 48 hrs of operator’s first scan
Cardiac Function
• R+0   •       
48 hr Blood Pressure (BP)/Holter/ 
Activity Monitoring
• Between L-75 & L-60 and L-21 & L-7
Resting Echo
• FD14 (±4 days), 30 (±5 days), 135 (±5 days), R-
15 (±4 days)
24 hr BP/Holter/Activity 
Monitoring
• R+0
Cardiac Function Exercise Echo MRI in Houston
• Between L-75 & L-60 • FD75 (±5 days) • R+3 and between R+22 & R+30
Magnetic Resonance Imaging (MRI) in 
Houston
• Between L-75 and L-60
24 hr BP/Holter/Activity Monitoring
• Within 1 week (preferably 3 days) of echo 
session (5 sessions)
MRI in Russia
• R+3 (if Russian landing)
MRI in Russia– if Russian landing Battery Change and Actiwatch Activation Exercise Echo/ECG     
• Between L-75 & Launch
    
• R-15 (once per increment)
 
• R+4 and R+14
Resting Echo/ECG
• Between L-21 & L-7
Actiwatch Activation
• Within 5 days of 24 hr BP/Holter/Activity 
Monitoring session (4 per increment)
Resting Echo/ECG
• R+7
Exercise/Medication Logs Hardware Data Download and Downlink Exercise/Medication Logs 
• L-105 through launch
    
• Within 5 days after echo + 24 hr sessions (5 per 
increment)
 
• R+0 through R+30
Exercise/Medication Logs
• Throughout Flight
T t l Ti ( i 6 th i i )Total Time
(assuming MRI in Russia is required)
12.4 hrs
o a  me assum ng -mon  m ss on
30.1 hrs nominal, 1.5 hrs reserve
NOTE:  Includes both subject and operator time  
Total Time
(assuming Russian landing)
12.2 hrs
Training
Session Title Session Type Timeframe
Session 
Duration
Location 
of 
Training
Required 
for 
Operators
Required 
for 
Subjects
Integrated Cardiovascular 
Overview and Hardware Demo
Task L-12 mo 1.5 hrs JSC X X
Integrated Cardiovascular 
Echocardiography Task Training
Task L-12 &
L-9 mo
2 @ 
1.5 hrs 
JSC X
each
Integrated Cardiovascular 
BP/Holter/Activity Monitor Nom 
Ops Training
Nominal L-9 mo 1.5 hrs JSC X X
Integrated Cardiovascular Exercise 
Echo Task Training
Task L-6 mo 2 hrs JSC X
Integrated Cardiovascular 
Echocardiography Nom Ops 
Training
Nominal L-6 mo 3 hrs JSC X X
Integrated Cardiovascular 
Integrated Training
Proficiency L-3 mo 3 hrs JSC X X
Integrated Cardiovascular OCBT
(Reserve)
OBT FD13 1 hr ISS X
Total:  14 hrs for subject-operator 
(both roles), 9 hrs as subject only
Experiment Success
• Quality images from inflight ultrasound 
i  i  k   R i  ti  d sess ons s ey. equ res pa ence, an
careful attention to the instructions of 
the remote guider;
• Lying still during MRI image acquisition.   
These can be long studies and it is easy 
to become restless;
• While wearing Holter monitor  need to ,
do some routine fitness exercise, and lie 
quietly for 10 minutes before you go to 
sleep
Experiment Benefits
• Better understanding of the function of the 
heart and blood vessels after spaceflight.
• Possible retirement of a number of 
cardiovascular “risks” of prolonged 
fl h  ( h  h h ) d/  space ig t suc as arr yt mias an or
determination that current hazard controls 
are sufficient for protection.
• Possible improvements in medical management 
on earth  particularly for conditions ,
regarding blood pressure control during 
standing or sudden cardiac death in 
otherwise healthy individuals.
